Division 1.6.1.2.5 Quality controls (QC) of the model
United Kingdom
Each batch of the epidermal model used should meet defined production release criteria, among which those for viability (paragraph 1.6.1.2.1) and for barrier function (paragraph 1.6.1.2.2) are the most relevant. An acceptability range (upper and lower limit) for the IC50 or the ET50 should be established by the skin model supplier (or investigator when using an in-house model). The barrier properties of the tissues should be verified by the laboratory after receipt of the tissues. Only results produced with qualified tissues can be accepted for reliable prediction of irritation effects. As an example, the acceptability ranges for the validated reference methods are given below.
Table 2
Examples of QC batch release criteria
| Lower acceptance limit | Mean of acceptance range | Upper acceptance limit | |
|---|---|---|---|
| Validated reference method 1 (18 hours treatment with SDS) | IC50 = 1,0 mg/ml | IC50 = 2,32 mg/ml | IC50 = 3,0 mg/ml |
| Validated reference method 2 (1 % Triton X-100) | ET50 = 4,8 hr | ET50 = 6,7 hr | ET50 = 8,7 hr |